Abstract
Background
Plasma exchange (PLEX) is a therapeutic option in the treatment of acute attacks of Demyelinating Diseases of the Central Nervous System (DDCNS). Factors related with PLEX response are not well established.
Methods
Descriptive and retrospective study. We included patients treated with PLEX for acute attacks of DDCNS between 2008 and 2017. We recorded demographics, clinical and treatment-related data, and Expanded Disability Status Scale (EDSS) score at admission, at discharge, and at 6 months.
Results
We included 64 patients. Forty-eight (75%) were female with a mean age of 48.28 ± 11.5 years. Half of our patients were diagnosed with multiple sclerosis. Clinical improvement was achieved in 51.6% at discharge and 62.5% at 6 months. The logistic regression model showed that EDSS score > 3 at admission (p = 0.04) and early clinical improvement with PLEX (p = 0.00) were predictors of good response to PLEX at discharge and at 6 months, respectively. No serious adverse effects were identified.
Conclusions
PLEX is a safe and effective treatment for acute attacks of DDCNS. EDSS score at admission and early clinical improvement with PLEX were factors associated with good response to PLEX.
Similar content being viewed by others
References
Llufriu S, Castillo J, Blanco Y, Ramio-Torrenta L, Rio J, Valles M, Lozano M, Castella MD, Calabia J, Horga A, Graus F, Montalban X, Saiz A (2009) Plasma exchange for acute attacks of CNS demyelination: predictors of improvement at 6 months. Neurology 73(12):949–953. https://doi.org/10.1212/WNL.0b013e3181b879be
Magaña S, Keegan B, Weinshenker B, Erickson B, Pittock S, Lennon V, Rodriguez M, Thomsen K, Weigand S, Mandrekar J, Linbo L, Lucchinetti CF (2012) Beneficial plasma exchange response in CNS inflammatory demyelination. Arch Neur 68(7):870–878. https://doi.org/10.1001/archneurol.2011.34
Tombak A, Uçar MA, Akdeniz A, Yilmaz A, Kaleagası H, Sungur MA, Tiftik EN (2017) Therapeutic plasma exchange in patients with neurologic disorders: review of 63 cases. Indian J Hematol Blood Transfus 33(1):97–105. https://doi.org/10.1007/s12288-016-0661-3
Láinez-Andrés JM, Gascón-Giménez F, Coret-Ferrer F, Casanova-Estruch B, Santonja JM (2015) Recambio plasmático terapéutico: aplicaciones en neurología. Rev NeurolRev Neurol 60(3):120–131. https://doi.org/10.33588/rn.6003.2014393
Kaya E, Keklik M, Şencan M, Yilmaz M, Keskin A, Kiki I et al (2013) Therapeutic plasma exchange in patients with neurological diseases: multicenter retrospective analysis. Transfus Apher SciTransfus Apher Sci 48(3):349–352. https://doi.org/10.1016/j.transci.2013.04.015
Correia I, Ribeiro JJ, Isidoro L, Batista S, Nunes C, Macário C et al (2018) Plasma exchange in severe acute relapses of multiple sclerosis – results from a Portuguese cohort. Mult Scler Relat Disord 19:148–152. https://doi.org/10.1016/j.msard.2017.12.001
Schröder A, Linker RA, Gold R (2010) Plasmapheresis for neuroinflammatory disorders. Clin Exp Neuroimmunol 1(3):95–102. https://doi.org/10.1111/j.1759-1961.2010.00010.x
Keegan M, König F, McClelland R, Brück W, Morales Y, Bitsch A et al (2005) Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange. Lancet 366(13):579–582. https://doi.org/10.1016/S0140-6736(05)67102-4
Weinshenker BG, O’Brien PC, Petterson TM, Noseworthy JH, Lucchinetti CF, Dodick DW et al (1999) A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol 46(6):878–886. https://doi.org/10.1002/1531-8249(199912)46:6<878::AID-ANA10>3.0.CO;2-Q
Keegan M, Pineda AA, McClelland RL, Darby CH, Rodriguez M, Weinshenker BG (2002) Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology 58(1):143–146. https://doi.org/10.1212/WNL.58.1.143
Ehler J, Koball S, Sauer M, Mitzner S, Hickstein H, Benecke R et al (2015) Response to therapeutic plasma exchange as a rescue treatment in clinically isolated syndromes and acute worsening of multiple sclerosis: a retrospective analysis of 90 patients. PLoS One 10(8):1–12. https://doi.org/10.1371/journal.pone.0134583
Watanabe S, Nakashima I, Misu T, Miyazawa I, Shiga Y, Fujihara K, Itoyama Y (2007) Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica. Mult SclerMult Scler 13:128–132. https://doi.org/10.1177/1352458506071174
Aungsumart S, Apiwattanakul M (2017) Clinical outcomes and predictive factors related to good outcomes in plasma exchange in severe attack of NMOSD and long extensive transverse myelitis: Case series and review of the literature. Mult Scler Relat Disord 13:93–97. https://doi.org/10.1016/j.msard.2017.02.015
Morgan S, Zantek N, Carpenter A (2014) Therapeutic plasma exchange in neuromyelitis optica: a case series. J Clin Apher 29:171–177. https://doi.org/10.1002/jca.21304
Lim YM, Pyun SY, Kang BH, Kim J, Kim KK (2013) Factors associated with the effectiveness of plasma exchange for the treatment of NMO-IgG-positive neuromyelitis optica spectrum disorders. Mult Scler JMult Scler J 19(9):1216–1218. https://doi.org/10.1177/1352458512471875
Greenberg B, Thomas K, Krishnan C, Kaplin A, Calabresi P, Kerr D (2007) Idiopathic transverse myelitis: corticosteroids, plasma exchange, or cyclophosphamide. Neurology 70(2):160. https://doi.org/10.1212/01.wnl.0000260970.63493.c8
Trebst C, Reising A, Kielstein JT, Hafer C, Stangel M (2009) Plasma exchange therapy in steroid-unresponsive relapses in patients with multiple sclerosis. Blood Purif 28(2):108–115. https://doi.org/10.1159/000224630
Funding
The authors received no financial support for the research, authorship, and/or publication of this article.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by Michael A. Palacios Mendoza, Pedro J. Melgarejo Otálora, Antonio Sánchez-Soblechero, José A. Aparcero-Suero, Sergio López Anguita, and José M. García Domínguez. The first draft of the manuscript was written by Michael A. Palacios Mendoza and José M. García Domínguez, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflicting of interest
The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Ethical approval
The study was approved by the Ethic Committee of General University Hospital “Gregorio Marañon”. This is specified in "Methods".
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Palacios-Mendoza, M.A., Martínez Ginés, M.L., Melgarejo Otálora, P.J. et al. Plasma exchange in acute attacks of demyelinating diseases of the central nervous system: clinical outcomes and predictors of response. Neurol Sci 41, 2569–2574 (2020). https://doi.org/10.1007/s10072-020-04382-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-020-04382-w